INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 151 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2015. The put-call ratio across all filers is 1.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,047,000 | -25.5% | 113,808 | -4.6% | 0.00% | -50.0% |
Q3 2016 | $1,406,000 | -4.6% | 119,284 | +4.7% | 0.00% | 0.0% |
Q2 2016 | $1,474,000 | -11.8% | 113,933 | +9.0% | 0.00% | 0.0% |
Q1 2016 | $1,671,000 | -52.3% | 104,527 | -14.6% | 0.00% | -50.0% |
Q4 2015 | $3,504,000 | +57.1% | 122,373 | +56.2% | 0.00% | +33.3% |
Q3 2015 | $2,230,000 | -22.5% | 78,341 | -2.2% | 0.00% | -25.0% |
Q2 2015 | $2,877,000 | +69.4% | 80,088 | +174.2% | 0.00% | +100.0% |
Q1 2015 | $1,698,000 | +39.8% | 29,206 | +1.4% | 0.00% | 0.0% |
Q4 2014 | $1,215,000 | +8.2% | 28,808 | -0.5% | 0.00% | 0.0% |
Q3 2014 | $1,123,000 | -52.9% | 28,952 | -62.0% | 0.00% | -33.3% |
Q2 2014 | $2,382,000 | +38.0% | 76,287 | +83.1% | 0.00% | 0.0% |
Q1 2014 | $1,726,000 | -25.3% | 41,668 | -30.2% | 0.00% | 0.0% |
Q4 2013 | $2,312,000 | +358.7% | 59,739 | +314.8% | 0.00% | +200.0% |
Q3 2013 | $504,000 | +176.9% | 14,402 | +9.4% | 0.00% | – |
Q2 2013 | $182,000 | – | 13,161 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 8,912,072 | $142,504,000 | 2.66% |
Antipodean Advisors LLC | 342,294 | $5,473,000 | 2.48% |
JW Asset Management, LLC | 221,538 | $3,542,000 | 2.31% |
Parametrica Management Ltd | 33,562 | $537,000 | 1.92% |
12 West Capital Management LP | 623,791 | $9,974,000 | 1.39% |
Folger Hill Asset Management LP | 1,418,138 | $22,676,000 | 1.27% |
Bellevue Group AG | 281,000 | $4,493,000 | 0.82% |
Plymouth Lane Capital Management, LLC | 55,300 | $884,000 | 0.78% |
Orbimed Advisors | 4,557,740 | $72,878,000 | 0.77% |
DIALECTIC CAPITAL MANAGEMENT, LP | 79,550 | $1,272,000 | 0.60% |